For example, viral vectors containing expressable CIITA, alone or in association with oncolytic viruses (agents that can overcome blood–brain barrier), could be used to target established GBM tumors and make them more immunogenic for triggering and/or increasing the stimulation of tumor-specific TH cells (72). This evidence concerns the gene CIITA and glioblastoma.